Silexion Therapeutics SLXN Income Statement (2023-2026)

NASDAQ SLXN
$0.40 -0.01 (-2.44%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & Cost
Interest income
Interest Income - Total (Quarter) 0.02M0.01M0.00M0.00M0.04M0.04M0.07M0.03M0.01M
Interest expenses
Interest Expenses (Quarter) 0.45M0.07M0.28M0.17M0.11M3.82M-4.07M0.09M0.22M-0.03M-0.21M0.06M-0.13M
Interest Income - Net (Quarter) -0.04M-0.04M-0.03M-0.02M-0.01M0.02M0.01M-0.04M-0.04M-0.07M-0.03M-0.01M
Operating Items
Research & Development (Quarter) 1.24M0.54M1.26M0.96M0.77M3.22M0.87M0.59M1.02M2.16M3.38M1.37M2.21M
Wages, Salaries and Other (Quarter) 0.01M0.16M
Selling, General & Administrative (Quarter) 0.18M0.20M0.47M0.29M0.62M4.82M1.03M1.06M1.27M1.14M1.03M1.38M1.47M
Restructuring Costs (Quarter) 0.01M0.01M
Other Operating Expenses (Quarter) -0.01M-0.01M
Operating Expenses (Quarter) 1.41M0.73M1.73M1.25M1.39M8.04M1.90M1.65M2.28M3.29M4.41M2.75M3.68M
Operating Income (Quarter) -1.41M-0.73M-1.73M-1.25M-1.39M-8.04M-1.90M-1.65M-2.28M-3.29M-4.41M-2.75M-3.68M
EBIT (Quarter) -1.41M-0.73M-1.73M-1.25M-1.39M-8.04M-1.90M-1.65M-2.28M-3.29M-4.41M-2.75M-3.68M
Net income details
EBT (Quarter) -1.87M-0.80M-1.67M-1.42M-1.49M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Tax Provisions (Quarter) 0.01M0.01M0.01M0.01M0.00M0.00M0.00M0.00M
Profit After Tax (Quarter) -1.88M-0.81M-1.68M-1.42M-1.49M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Income from Non-Controlling Interests (Quarter) 0.22M0.02M-0.05M0.05M0.02M0.01M
Income from Continuing Operations (Quarter) -1.88M-0.81M-1.68M-1.42M-1.49M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Consolidated Net Income (Quarter) -1.88M-0.81M-1.68M-1.42M-1.49M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Income towards Parent Company (Quarter) -1.88M-0.81M-1.68M-1.42M-1.49M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Net Income towards Common Stockholders (Quarter) 1.65M-0.81M-1.68M-1.42M1.47M-11.86M-1.75M-1.74M-2.50M-3.26M-4.41M-2.73M-3.55M
Additional items
EPS (Basic) (Quarter) 0.01M-0.00M-0.00M-0.00M0.01M-0.00M-420.05-38.39-43.19-28.80-33.18-8.46-5.17
EPS (Diluted) (Quarter) 0.01M-0.00M-0.00M-0.00M0.01M-0.00M-420.05-38.39-43.19-28.80-33.18-8.46-5.17
Shares Outstanding (Quarter) 187.00745.00745.00745.00186.000.00M0.00M0.05M0.06M0.11M0.13M0.32M0.69M
Shares Outstanding (Diluted) (Quarter) 187.00745.00745.00745.00186.000.00M0.00M0.05M0.06M0.11M0.13M0.32M0.69M
Shares Outstanding (Entity) (Quarter) 187.00647.00745.00745.00186.000.00M0.00M0.05M0.06M0.11M0.13M0.34M0.69M
EBITDA (Quarter) -1.41M-0.73M-1.73M-1.25M-1.39M-8.04M-1.90M-1.65M-2.28M-3.29M-4.41M-2.75M-3.68M